All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.


Improving the Safety of Compounding Sterile Products

Activity Downloads

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.

NOTE: If you attended the live CE activity titled "Improving the Safety of Compounding Sterile Products" that was held on December 8, 2015 during the 50th ASHP Midyear Clinical Meeting & Exhibition in New Orleans, Louisiana AND received CE credit (i.e. a pharmacist CE statement with ACPE Universal Activity Number 0221-9999-15-256-L05-P), you are NOT allowed to also receive CE credit for this home-study activity.

Activity Description

Serious errors involving sterile drug compounding continue to be reported. This activity will explore current safety issues and causes of sterile compounding errors, and provide practical recommendations for reducing the risk of patient harm. Leading national experts will discuss actual cases where errors have occurred and best practices, technology, and automated solutions that can improve safety. The activity also will provide an overview of new and proposed regulatory and Joint Commission accreditation requirements and newly revised ISMP guidelines related to sterile compounding.

Learning Objectives

The target audience for this activity includes pharmacists. Upon completion of this activity, participants will be able to:

  • Identify system-based causes of medication errors associated with sterile preparation and compounding in hospitals.
  • Prioritize selected strategies to prevent harm and improve medication safety with sterile preparation and compounding in hospitals.
  • Discuss the results of a recent study that demonstrated the inaccuracy of the syringe “pull-back” method for checking IV compounded products.
  • Explain how automation and technology can reduce errors related to sterile preparation.
  • Outline current and proposed regulatory and accreditation requirements related to sterile preparation and compounding activities in hospitals, and the role of the pharmacy in ensuring compliance.
  • Describe the recent revisions to ISMP’s Guidelines for the Safe Preparation of Sterile Compounds, and new ISMP guidelines for IV push administration of medications (as it relates to pharmacy preparation).


Michael R. Cohen, RPh, MS, ScD (hon), DPS (hon), FASHP
Institute for Safe Medication Practices
Horsham, Pennsylvania

Stephen F. Eckel, PharmD, MHA, BCPS
Clinical Associate Professor
UNC Eshelman School of Pharmacy
Associate Director
University of North Carolina Hospitals
Chapel Hill, North Carolina

Christina Michalek, RPh, BS, FASHP
Medication Safety Specialist
Institute for Safe Medication Practices
Horsham, Pennsylvania

Darryl S. Rich, PharmD, MBA, FASHP
Medication Safety Specialist
Institute for Safe Medication Practices
Horsham, Pennsylvania


It is the policy of ISMP and ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Michael Cohen, Christina Michalek, and Darryl Rich have no relevant commercial and/or financial relationships to disclose. Stephen Eckel has received grant/research support from BD, Baxter & Carefusion foundation. He has received financial support as a consultant/speaker for BD.

Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

CE Accreditation

Release Date: 02-15-2016
Expiration Date: 02-15-2018


This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-16-021-H05-P has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers, and is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. CE credit will be uploaded to NABP/CPE Monitor. No partial credit will be given.


This activity is supported by an educational grant from BD.


The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Activity Announcement